Bayer Low Dose Ads Urge Consumers To “Do More” In Cardiac Prevention
This article was originally published in The Tan Sheet
Executive Summary
Bayer seeks to increase consumer awareness of low-dose aspirin for primary prevention of heart attacks in a television spot that broke June 23
You may also be interested in...
Aspirin For MI Primary Prevention Indication Needs More Study, Panel Says
A long-term randomized prospective trial of at least 15,000 patients would be needed to adequately support professional aspirin labeling on primary prevention of myocardial infarction, according to members of FDA's Cardiovascular & Renal Drugs Advisory committee
Aspirin MI Primary Prevention Labeling Urged In Bayer Citizen Petition
Aspirin therapy led to a statistically significant 32% reduction in first myocardial infarctions among over 55,000 subjects evaluated in a meta-analysis of five primary prevention studies conducted by Bayer Consumer Care
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC